Shallcross Steven a, CEO and CFO at Theriva Biologics, Inc. (TOVX), bought 25,000 shares at $1.04 ($26K) on 2023-02-10, disclosed to the SEC on 2023-02-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| TOVX | BUY | 2023-02-03 | $24K | — | Filing → |
| TOVX | BUY | 2023-01-26 | $22K | — | Filing → |
| TOVX | BUY | 2023-01-23 | $19K | — | Filing → |